terican

Last verified · v1.0

Calculator · health

Pediatric Glomerular Filtration Rate (Gfr) Calculator

Estimate kidney function in children using the Bedside Schwartz (CKiD 2009) or Classic Schwartz equation. Enter height and serum creatinine to calculate pediatric eGFR instantly.

FreeInstantNo signupOpen source

Inputs

Estimated Glomerular Filtration Rate (eGFR)

—

Explain my result

0/3 free

Get a plain-English breakdown of your result with practical next steps.

Estimated Glomerular Filtration Rate (eGFR)—mL/min/1.73 m²

The formula

How the
result is
computed.

Understanding the Pediatric Glomerular Filtration Rate Calculator

Glomerular filtration rate (GFR) measures how efficiently the kidneys filter metabolic waste from the blood, expressed in mL/min/1.73 m². In children, accurate GFR estimation is critical for diagnosing chronic kidney disease (CKD), calibrating drug dosages, and tracking renal function longitudinally. The pediatric GFR calculator implements two validated Schwartz equations that derive eGFR from height and serum creatinine (SCr), eliminating the need for 24-hour urine collections in routine clinical practice.

The Schwartz Equation: Background and Development

George Schwartz first published his bedside proportionality formula in 1976, demonstrating that the height-to-SCr ratio correlates closely with measured GFR in children. The original Classic Schwartz equation uses age- and sex-specific proportionality constants (k) that account for the progressive increase in muscle mass across pediatric developmental stages. These k values range from 0.33 for low-birth-weight infants to 0.70 for adolescent males.

In 2009, the Chronic Kidney Disease in Children (CKiD) study published a revised formula now universally called the Bedside Schwartz equation, derived from children aged 1 to 16 years with CKD and IDMS-traceable creatinine assays. This recalibration produced a single unified constant of k = 0.413, replacing multiple age- and sex-specific values and substantially improving accuracy with contemporary laboratory methods. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) endorses this formula as the current standard for pediatric GFR estimation.

Formula and Variables Explained

Both Schwartz equations share the same algebraic structure:

eGFR = (k x Height in cm) / Serum Creatinine in mg/dL

  • k (proportionality constant): Bedside Schwartz applies k = 0.413 universally. Classic Schwartz uses 0.33 for low-birth-weight infants, 0.45 for full-term infants under 1 year, 0.55 for children aged 1 to 12 and adolescent females, and 0.70 for adolescent males.
  • Height: Measured in centimeters using standing height for children aged 2 and older, or recumbent length for infants. A 5 cm measurement error in a child with an SCr of 0.6 mg/dL alters the eGFR estimate by approximately 3.4 mL/min/1.73 m², so precision is essential.
  • Serum Creatinine (SCr): Reported in mg/dL. For Bedside Schwartz, the laboratory must use an IDMS-traceable creatinine method. Older Jaffe colorimetric or non-standardized enzymatic assays inflate SCr values, artificially suppressing eGFR results and potentially overcalling CKD.

Worked Clinical Example

Consider a 10-year-old child, height 138 cm, SCr 0.7 mg/dL. Using Bedside Schwartz: eGFR = (0.413 x 138) / 0.7 = 56.994 / 0.7 = 81.4 mL/min/1.73 m². This falls within the G2 mildly reduced range (60 to 89) under KDIGO staging, warranting close monitoring. For comparison, applying Classic Schwartz with k = 0.55 yields eGFR = (0.55 x 138) / 0.7 = 108.4 mL/min/1.73 m² - a 27-unit difference driven entirely by the k constant, illustrating why assay calibration and equation selection carry direct clinical consequences.

CKD Staging in Children

KDIGO applies the same eGFR thresholds in children as in adults: G1 (90 or above, normal or high), G2 (60 to 89, mildly decreased), G3a (45 to 59), G3b (30 to 44), G4 (15 to 29, severely decreased), and G5 (below 15, kidney failure). An eGFR below 60 mL/min/1.73 m² sustained for more than 3 months confirms CKD in a child and warrants nephrology referral.

Limitations and Clinical Context

The Bedside Schwartz equation was developed in a CKD cohort and may overestimate GFR in children with normal kidney function. Neither Schwartz formula applies reliably to neonates in the first week of life (whose SCr still reflects maternal clearance), children with severe muscle wasting or obesity, or patients taking creatinine-altering medications. For irreversible decisions such as transplant listing, confirmatory measured GFR using iohexol or inulin clearance is advisable. A 2019 review published by PMC (Pediatric GFR Estimation Formulas) compares Schwartz variants against the Full Age Spectrum equation and cystatin-C-based formulas. Validated CKiD calculators are also available through the Johns Hopkins Bloomberg School of Public Health CKiD resource center for clinicians seeking additional validation tools.

Reference

Frequently asked questions

What is a normal GFR for a child?
Normal GFR in children varies considerably with age. Newborns start around 20 to 30 mL/min/1.73 m² and reach adult-equivalent values of 90 to 120 mL/min/1.73 m² by approximately age 2. Under KDIGO guidelines, an eGFR at or above 90 mL/min/1.73 m² is considered normal for children aged 2 and older, provided no other markers of kidney damage such as proteinuria or structural abnormalities are present.
What is the difference between the Classic Schwartz and Bedside Schwartz equations?
The Classic Schwartz equation (1976) uses multiple age- and sex-specific k constants ranging from 0.33 to 0.70, calibrated for older creatinine assay methods. The Bedside Schwartz equation (CKiD, 2009) applies a single unified k of 0.413, recalibrated specifically for IDMS-traceable creatinine methods now standard in modern clinical laboratories. Bedside Schwartz demonstrates superior accuracy with contemporary assays and is the current recommended standard for children aged 1 to 16 with CKD.
Which k value should be used for a 14-year-old male in the Classic Schwartz equation?
For an adolescent male using the Classic Schwartz equation, the correct k value is 0.70. This higher constant reflects the substantially greater muscle mass in teenage boys compared to younger children or females, which elevates creatinine production and raises the height-to-SCr proportionality ratio. Applying k = 0.55 for an adolescent male would systematically underestimate GFR, potentially misclassifying normal kidney function as mildly reduced.
Can the Schwartz eGFR replace a measured GFR in children?
For routine CKD monitoring and staging, the Bedside Schwartz eGFR is clinically sufficient and avoids invasive procedures. However, measured GFR using iohexol or inulin clearance remains the gold standard when high-stakes decisions are involved, such as kidney donor evaluation, transplant listing, or eligibility assessment for nephrotoxic chemotherapy. Schwartz eGFR carries an inherent individual-level margin of error of approximately 10 to 30 percent, which matters when precision is paramount.
Why must serum creatinine be IDMS-traceable when using the Bedside Schwartz equation?
The CKiD study that derived the Bedside Schwartz k value of 0.413 used creatinine measurements standardized to the IFCC reference method through IDMS traceability. Older Jaffe colorimetric or non-standardized enzymatic assays report creatinine values up to 20 percent higher than IDMS-traceable results. Entering an inflated SCr into the Bedside Schwartz formula produces a falsely low eGFR, potentially triggering unnecessary clinical interventions or a misdiagnosis of CKD in a child with entirely normal kidney function.
At what eGFR level should a child be referred to a pediatric nephrologist?
Clinical guidelines generally recommend nephrology referral when a child's eGFR falls below 60 mL/min/1.73 m² (CKD stage G3a or worse) persisting for more than 3 months, or sooner if there is rapid eGFR decline, heavy proteinuria, hypertension, or suspected glomerulopathy. Earlier referral at eGFR 60 to 89 mL/min/1.73 m² is appropriate when a structural or hereditary renal condition is identified, enabling proactive management strategies to slow progression toward kidney failure.